Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant.
Annals of surgical oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined